Cargando…

Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis

BACKGROUND: The COVID-19 has caused significant mortality and morbidity across the globe. Patients with cancer are especially vulnerable given their immunocompromised state. We aimed to determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Shuting, Zhuang, Qingyuan, Chiang, Jianbang, Tan, Sze Huey, Chua, Gail Wan Ying, Xie, Conghua, Chua, Melvin L K, Soon, Yu Yang, Yang, Valerie Shiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822543/
https://www.ncbi.nlm.nih.gov/pubmed/35131810
http://dx.doi.org/10.1136/bmjopen-2020-044661
_version_ 1784646623814483968
author Han, Shuting
Zhuang, Qingyuan
Chiang, Jianbang
Tan, Sze Huey
Chua, Gail Wan Ying
Xie, Conghua
Chua, Melvin L K
Soon, Yu Yang
Yang, Valerie Shiwen
author_facet Han, Shuting
Zhuang, Qingyuan
Chiang, Jianbang
Tan, Sze Huey
Chua, Gail Wan Ying
Xie, Conghua
Chua, Melvin L K
Soon, Yu Yang
Yang, Valerie Shiwen
author_sort Han, Shuting
collection PubMed
description BACKGROUND: The COVID-19 has caused significant mortality and morbidity across the globe. Patients with cancer are especially vulnerable given their immunocompromised state. We aimed to determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA). METHODS: Systematic review was performed through online databases, PubMed, Medline and Google Scholar, with keywords listed in the Methods section (1 November 2019–31 December 2020). Studies with clinical outcomes of at least 10 COVID-19 patients and at least one with a diagnosis of cancer were included. The studies for MA were assessed with PRISMA guidelines and appraised with Newcastle-Ottawa Scale. The data were pooled using a random-effects model using STATA software. The main outcomes were planned before data collection, including proportion of patients with cancer among COVID-19 populations, relative risk (RR) of severe outcomes and death of patients with cancer compared with general COVID-19 patients. RESULTS: We identified 57 case series (63 413 patients), with 230 patients with cancer with individual patient data (IPD). We found that the pooled proportion of cancer among COVID-19 patients was 0.04 (95% CI 0.03 to 0.05, I(2)=97.69%, p<0.001). The pooled RR of death was 1.44 (95% CI 1.19 to 1.76) between patients with cancer and the general population with COVID-19 infection. The pooled RR of severe outcome was 1.49 (95% CI 1.18 to 1.87) between cancer and general COVID-19 patients. The presence of lung cancer and stage IV cancer did not result in significantly increased RR of severe outcome. Among the available IPD, only age and gender were associated with severe outcomes. CONCLUSION: Patients with cancer were at a higher risk of severe and death outcomes from COVID-19 infection as compared with general COVID-19 populations. Limitations of this study include publication bias. A collaborative effort is required for a more complete database.
format Online
Article
Text
id pubmed-8822543
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88225432022-02-09 Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis Han, Shuting Zhuang, Qingyuan Chiang, Jianbang Tan, Sze Huey Chua, Gail Wan Ying Xie, Conghua Chua, Melvin L K Soon, Yu Yang Yang, Valerie Shiwen BMJ Open Oncology BACKGROUND: The COVID-19 has caused significant mortality and morbidity across the globe. Patients with cancer are especially vulnerable given their immunocompromised state. We aimed to determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA). METHODS: Systematic review was performed through online databases, PubMed, Medline and Google Scholar, with keywords listed in the Methods section (1 November 2019–31 December 2020). Studies with clinical outcomes of at least 10 COVID-19 patients and at least one with a diagnosis of cancer were included. The studies for MA were assessed with PRISMA guidelines and appraised with Newcastle-Ottawa Scale. The data were pooled using a random-effects model using STATA software. The main outcomes were planned before data collection, including proportion of patients with cancer among COVID-19 populations, relative risk (RR) of severe outcomes and death of patients with cancer compared with general COVID-19 patients. RESULTS: We identified 57 case series (63 413 patients), with 230 patients with cancer with individual patient data (IPD). We found that the pooled proportion of cancer among COVID-19 patients was 0.04 (95% CI 0.03 to 0.05, I(2)=97.69%, p<0.001). The pooled RR of death was 1.44 (95% CI 1.19 to 1.76) between patients with cancer and the general population with COVID-19 infection. The pooled RR of severe outcome was 1.49 (95% CI 1.18 to 1.87) between cancer and general COVID-19 patients. The presence of lung cancer and stage IV cancer did not result in significantly increased RR of severe outcome. Among the available IPD, only age and gender were associated with severe outcomes. CONCLUSION: Patients with cancer were at a higher risk of severe and death outcomes from COVID-19 infection as compared with general COVID-19 populations. Limitations of this study include publication bias. A collaborative effort is required for a more complete database. BMJ Publishing Group 2022-02-07 /pmc/articles/PMC8822543/ /pubmed/35131810 http://dx.doi.org/10.1136/bmjopen-2020-044661 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Han, Shuting
Zhuang, Qingyuan
Chiang, Jianbang
Tan, Sze Huey
Chua, Gail Wan Ying
Xie, Conghua
Chua, Melvin L K
Soon, Yu Yang
Yang, Valerie Shiwen
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
title Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
title_full Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
title_fullStr Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
title_full_unstemmed Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
title_short Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
title_sort impact of cancer diagnoses on the outcomes of patients with covid-19: a systematic review and meta-analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822543/
https://www.ncbi.nlm.nih.gov/pubmed/35131810
http://dx.doi.org/10.1136/bmjopen-2020-044661
work_keys_str_mv AT hanshuting impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT zhuangqingyuan impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT chiangjianbang impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT tanszehuey impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT chuagailwanying impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT xieconghua impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT chuamelvinlk impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT soonyuyang impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis
AT yangvalerieshiwen impactofcancerdiagnosesontheoutcomesofpatientswithcovid19asystematicreviewandmetaanalysis